AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,519,000 | – | 275,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,792,773 | $12,260,000 | 1.80% |
| JW Asset Management, LLC | 444,439 | $1,951,000 | 1.05% |
| BRANDES INVESTMENT PARTNERS, LP | 6,335,548 | $27,813,000 | 0.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $11,951,000 | 0.43% |
| Ghost Tree Capital, LLC | 450,000 | $1,976,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $3,576,000 | 0.13% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 32,250 | $142,000 | 0.10% |
| Portolan Capital Management | 150,600 | $661,000 | 0.06% |
| Brown Capital Management | 1,010,177 | $4,435,000 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,120,215 | $4,917,000 | 0.02% |